About Cardiotrack
Cardiotrack is a pioneering health-tech company that is redefining preventive and insurance policy-based medical screenings through its advanced AgenticAI-driven platform, Ethos.AI. The company has built an extensive network of over 1,600 diagnostic labs across more than 600 cities, providing 80% population reach across its markets. Cardiotrack has transformed the at-home health screening landscape by enabling complex diagnostic tests such as ECGs and stress tests (equivalent to treadmill tests) to be conducted in patients' homes. The company's end-to-end automation platform ensures faster case closures, reduces discrepancies, and delivers an exceptional customer experience. With over 400,000 individuals screened and partnerships with more than 10 insurance customers, Cardiotrack serves insurers, corporates, diagnostic labs, and individuals seeking comprehensive health checkups. The platform integrates data analytics, process automation, support automation, report quality checks, and tele-ECG capabilities to streamline the entire health screening workflow. Cardiotrack is trusted by leading insurers for delivering reliable, technology-enabled preventive health screening solutions.
Mission & Story
Mission
Shaping the Future of Health Screening
Clinical Focus
Medical conditions and clinical areas addressed by Cardiotrack.
Who It Serves
Milestones & Awards
Recent Milestones
Expanded to 1,600+ lab network across 600+ cities; introduced at-home stress ECG testing equivalent to treadmill tests; added advanced radiology tests to at-home screening portfolio
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.